Edwards Lifesciences Corporation (EW) Q1 2022 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Down 2.95%

Edwards Lifesciences reported earnings that exceeded expectations on EPS, but the stock fell by nearly 3%. This decline may reflect investor concerns or broader market conditions, as no revenue data or guidance was provided to clarify future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.60	N/A	+4.17%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Edwards Lifesciences Beats on EPS, Stock Down 2.95%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Down 2.95%

Key numbers

Management commentary